BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1413 related articles for article (PubMed ID: 33030668)

  • 1. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
    Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
    Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
    Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in-silico studies and biological screening of quinazolinone analogues as potential antibacterial agents against MRSA.
    Qureshi SI; Chaudhari HK
    Bioorg Med Chem; 2019 Jun; 27(12):2676-2688. PubMed ID: 31103406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
    Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).
    Novais JS; Rosandiski AC; de Carvalho CM; de Saules Silva LS; Dos S Velasco de Souza LC; Santana MV; Martins NRC; Castro HC; Ferreira VF; Gonzaga DTG; de Resende GO; de C da Silva F
    Curr Top Med Chem; 2020; 20(2):121-131. PubMed ID: 31820692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fluoroquinolones analogues bearing 4-(arylcarbamoyl)benzyl: design, synthesis, and antibacterial evaluation.
    Peytam F; Norouzbahari M; Saadattalab T; Şanlıtürk G; Firoozpour L; Emamgholipour Z; Dogaheh MG; Nikou M; Tehrani MB; Bijanzadeh HR; Güran M; Foroumadi A
    Mol Divers; 2023 Jul; ():. PubMed ID: 37420079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
    Zhang YB; Feng LS; You XF; Guo Q; Guo HY; Liu ML
    Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
    Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
    Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
    Foroumadi A; Firoozpour L; Emami S; Mansouri S; Ebrahimabadi AH; Asadipour A; Amini M; Saeid-Adeli N; Shafiee A
    Arch Pharm Res; 2007 Feb; 30(2):138-45. PubMed ID: 17366732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives.
    Mohammed AAM; Suaifan GARY; Shehadeh MB; Okechukwu PN
    Eur J Med Chem; 2020 Sep; 202():112513. PubMed ID: 32623216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens.
    Ahmed A; Molvi KI; Patel HM; Ullah R; Bari A
    J Infect Public Health; 2020 Apr; 13(4):472-479. PubMed ID: 32139293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,1'-Carbonyldiimidazole (CDI) Mediated Facile Synthesis, Structural Characterization, Antimicrobial Activity, and in-silico Studies of Coumarin- 3-carboxamide Derivatives.
    Salar U; Khan KM; Fakhri MI; Hussain S; Tauseef S; Ameer S; Wadood A; Khan H; Perveen S
    Med Chem; 2018; 14(1):86-101. PubMed ID: 28641525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
    Fedorowicz J; Sączewski J; Konopacka A; Waleron K; Lejnowski D; Ciura K; Tomašič T; Skok Ž; Savijoki K; Morawska M; Gilbert-Girard S; Fallarero A
    Eur J Med Chem; 2019 Oct; 179():576-590. PubMed ID: 31279292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
    Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
    ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
    Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
    Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones.
    Hutchings KM; Tran TP; Ellsworth EL; Watson BM; Sanchez JP; Showalter HD; Stier MA; Shapiro M; Themis Joannides E; Huband M; Nguyen DQ; Maiti S; Li T; Tailor J; Thomas G; Ha C; Singh R
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5087-90. PubMed ID: 18752951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.
    Türe A; Kulabaş N; Dingiş Sİ; Birgül K; Bozdeveci A; Alpay Karaoğlu Ş; Krishna VS; Sriram D; Küçükgüzel İ
    Bioorg Chem; 2019 Jul; 88():102965. PubMed ID: 31085371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
    Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
    Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.